List of Excipients in API infliximab-dyyb
✉ Email this page to a colleague
Detailed excipient profiles for infliximab-dyyb
Excipient focus: ACETIC ACID
infliximab-dyyb drug variants containing ACETIC ACID
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA Inc | infliximab-dyyb | 72606-025 |
>Company | >Ingredient | >NDC |
infliximab-dyyb drug variants not containing ACETIC ACID
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | infliximab-dyyb | 0069-0809 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
infliximab-dyyb drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | infliximab-dyyb | 0069-0809 |
CELLTRION USA Inc | infliximab-dyyb | 72606-025 |
>Company | >Ingredient | >NDC |
infliximab-dyyb drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
infliximab-dyyb drug variants containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA Inc | infliximab-dyyb | 72606-025 |
>Company | >Ingredient | >NDC |
infliximab-dyyb drug variants not containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | infliximab-dyyb | 0069-0809 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
infliximab-dyyb drug variants containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | infliximab-dyyb | 0069-0809 |
>Company | >Ingredient | >NDC |
infliximab-dyyb drug variants not containing SODIUM PHOSPHATE, DIBASIC, DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA Inc | infliximab-dyyb | 72606-025 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
infliximab-dyyb drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | infliximab-dyyb | 0069-0809 |
>Company | >Ingredient | >NDC |
infliximab-dyyb drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA Inc | infliximab-dyyb | 72606-025 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
infliximab-dyyb drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA Inc | infliximab-dyyb | 72606-025 |
>Company | >Ingredient | >NDC |
infliximab-dyyb drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | infliximab-dyyb | 0069-0809 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
infliximab-dyyb drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Pfizer Laboratories Div Pfizer Inc | infliximab-dyyb | 0069-0809 |
>Company | >Ingredient | >NDC |
infliximab-dyyb drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA Inc | infliximab-dyyb | 72606-025 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.